Pasithea Therapeutics Corp. (KTTAW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1111 Lincoln Road
Miami Beach, FL 33139
United States of America (the)
Phone
702-514-4174
Website
Sector
Healthcare
Industry
Biotechnology
Employees
4
First IPO Date
September 15, 2021
| Name | Title | Pay | Year Born |
| Tiago Reis Marques | Chief Executive Officer & Director | 1.05M | 1978 |
| Lawrence Steinman | Co-Founder & Executive Chairman | 208,751 | 1948 |
| Daniel H. Schneiderman | Chief Financial Officer | 716,884 | 1978 |
| Kartik Krishnan | Chief Medical Officer | 0 | N/A |
Pasithea Therapeutics Corp. is a biotechnology firm dedicated to exploring and developing therapies for various psychiatric and neurological conditions. Beyond its research endeavors, the company intends to establish clinics specializing in the treatment of depression. At these facilities, certified pharmacists will administer intravenous ketamine infusions, and the firm will also extend business support services for these operations. Founded in 2020, Pasithea Therapeutics Corp. maintains its corporate headquarters in Miami Beach, Florida.